179 related articles for article (PubMed ID: 26554732)
1. Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis.
Kawano S; Komai Y; Ishioka J; Sakai Y; Fuse N; Ito M; Kihara K; Saito N
Minerva Urol Nefrol; 2016 Oct; 68(5):437-43. PubMed ID: 26554732
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
4. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
Asakawa J; Iguchi T; Tamada S; Ninomiya N; Kato M; Yamasaki T; Nakatani T
Int J Urol; 2018 Mar; 25(3):258-262. PubMed ID: 29194771
[TBL] [Abstract][Full Text] [Related]
6. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
7. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
8. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
11. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
Izumi K; Mizokami A; Maeda Y; Koh E; Namiki M
J Urol; 2011 Feb; 185(2):556-61. PubMed ID: 21168872
[TBL] [Abstract][Full Text] [Related]
12. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
[TBL] [Abstract][Full Text] [Related]
13. Single Versus Double Ureteral Stent Placement After Laser Endoureterotomy for the Management of Benign Ureteral Strictures: A Randomized Clinical Trial.
Ibrahim HM; Mohyelden K; Abdel-Bary A; Al-Kandari AM
J Endourol; 2015 Oct; 29(10):1204-9. PubMed ID: 26102617
[TBL] [Abstract][Full Text] [Related]
14. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
[TBL] [Abstract][Full Text] [Related]
15. Retrograde stenting for obstruction of the renal transplant ureter.
Gerrard ER; Burns JR; Young CJ; Urban DA; Hammontree LN; El-Galley R; Kolettis PN
Urology; 2005 Aug; 66(2):256-60; discussion 260. PubMed ID: 16098351
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction.
Kim JW; Hong B; Shin JH; Park J; Kim JH; Gwon DI; Ryu MH; Ryoo BY
Korean J Radiol; 2018; 19(4):606-612. PubMed ID: 29962867
[TBL] [Abstract][Full Text] [Related]
18. Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies.
Chow PM; Hsu JS; Wang SM; Yu HJ; Pu YS; Liu KL
World J Urol; 2014 Jun; 32(3):729-36. PubMed ID: 23933664
[TBL] [Abstract][Full Text] [Related]
19. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
[TBL] [Abstract][Full Text] [Related]
20. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
